| Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission D Stolz, T Mkorombindo, DM Schumann, A Agusti, SY Ash, M Bafadhel, ... The Lancet 400 (10356), 921-972, 2022 | 292 | 2022 |
| Longitudinal association between muscle loss and mortality in ever smokers SE Mason, R Moreta-Martinez, WW Labaki, MJ Strand, EA Regan, J Bon, ... Chest 161 (4), 960-970, 2022 | 20 | 2022 |
| Towards the elimination of chronic obstructive pulmonary disease: a D Stolz, T Mkorombindo, DM Schumann, A Agusta, SY Ash, M Bafadhel Lancet, 921-972, 0 | 20 | |
| Mepolizumab in the treatment of eosinophilic chronic obstructive pulmonary disease T Mkorombindo, MT Dransfield International Journal of Chronic Obstructive Pulmonary Disease, 1779-1787, 2019 | 17 | 2019 |
| Impact of quality improvement on care of chronic obstructive pulmonary disease patients in an internal medicine resident clinic RM Burkes, T Mkorombindo, U Chaddha, A Bhatt, K El-Kersh, ... Healthcare 6 (3), 88, 2018 | 14 | 2018 |
| Inhaled corticosteroids in chronic obstructive pulmonary disease: benefits and risks T Mkorombindo, MT Dransfield Clinics in chest medicine 41 (3), 475-484, 2020 | 13 | 2020 |
| Correlates of survival after autoantibody reduction therapy for acute IPF exacerbations T Kulkarni, VG Valentine, F Fei, TK Tran-Nguyen, LD Quesada-Arias, ... PLoS one 16 (11), e0260345, 2021 | 10 | 2021 |
| Risk of COPD exacerbation is increased by poor sleep quality and modified by social adversity A Baugh, RG Buhr, P Quibrera, I Barjaktarevic, RG Barr, R Bowler, ... Sleep 45 (8), zsac107, 2022 | 9 | 2022 |
| HLA-C and KIR permutations influence chronic obstructive pulmonary disease risk T Mkorombindo, TK Tran-Nguyen, K Yuan, Y Zhang, J Xue, GJ Criner, ... JCI insight 6 (19), 2021 | 9 | 2021 |
| Heart rate variability on 10-second electrocardiogram and risk of acute exacerbation of COPD: a secondary analysis of the BLOCK COPD trial DM MacDonald, T Mkorombindo, SX Ling, S Adabag, R Casaburi, ... Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation 9 (2 …, 2022 | 7 | 2022 |
| Lung function and the risk of exacerbation in the β-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease trial TM Parekh, ES Helgeson, J Connett, H Voelker, SX Ling, SC Lazarus, ... Annals of the American Thoracic Society 19 (10), 1642-1649, 2022 | 6 | 2022 |
| Pre-chronic obstructive pulmonary disease: a pathophysiologic process or an opinion term? T Mkorombindo, MT Dransfield Current Opinion in Pulmonary Medicine 28 (2), 109-114, 2022 | 5 | 2022 |
| COPD: COagulation‐associated Pulmonary Disease? T Mkorombindo, MT Dransfield Respirology 26 (4), 2021 | 4 | 2021 |
| Supportive care of right ventricular failure due to fat embolism syndrome KT Schwalbach, RC Wade, T Mkorombindo, SK McElwee, JM Wells, ... Respiratory Medicine Case Reports 34, 101499, 2021 | 3 | 2021 |
| COPD exacerbations and MACE: More than a chance encounter? T Mkorombindo, MT Dransfield Respirology 24 (12), 2019 | 3 | 2019 |
| Eosinophil-guided treatment of COPD exacerbations: unfinished business T Mkorombindo, M Dransfield The Lancet Respiratory Medicine 7 (8), 647-648, 2019 | 3 | 2019 |
| Chronotropic index during 6-minute walk and acute respiratory events in COPDGene DM Macdonald, EF Palzer, A Abbasi, AK Baldomero, SP Bhatt, ... Respiratory medicine 194, 106775, 2022 | 2 | 2022 |
| The air we breathe: respiratory impact of indoor air quality in chronic obstructive pulmonary disease T Mkorombindo, JR Balmes, A Custovic, MT Dransfield American Journal of Respiratory and Critical Care Medicine 205 (4), 378-380, 2022 | 2 | 2022 |
| Journal Club: Biologics and Potential for Immune Modulation in Chronic Obstructive Lung Disease T Mkorombindo, R Balkissoon Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation 9 (2 …, 2022 | 2 | 2022 |
| Journal Club: Respiratory Impact of Wildfire Smoke T Mkorombindo, R Balkissoon Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation 8 (3 …, 2021 | 2 | 2021 |
